MedElevator Войти в исследования
← Поиск публикаций

DOI 10.14309/ajg.0000000000002772

Медицинская библиотека · The American journal of gastroenterology · 2024

Pancreatic Enzyme Use Reduces Pancreatitis Frequency in Children With Acute Recurrent or Chronic Pancreatitis: A Report From INSPPIRE.

Freeman Alvin Jay, Ng Kenneth, Wang Fuchenchu, Abu-El-Haija Maisam A, Chugh Ankur, Cress Gretchen A, Fishman Douglas S, Gariepy Cheryl E, Giefer Matthew J, Goday Praveen, Gonska Tanja Y, Grover Amit S, Lindblad Douglas, Liu Quin Y, Maqbool Asim, Mark Jacob A, McFerron Brian A, Mehta Megha S, Morinville Veronique D, Noel Robert A, Ooi Chee Y, Perito Emily R, Schwarzenberg Sarah Jane, Sellers Zachary M, Wilschanski Michael, Zheng Yuhua, Yuan Ying, Andersen Dana K, Lowe Mark E, Uc Aliye, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC)

СтатьяПоддержка NIH: внешняя программаПеревод в очереди

Аннотация

INTRODUCTION

Among children who suffer from acute recurrent pancreatitis (ARP) or chronic pancreatitis (CP), acute pancreatitis (AP) episodes are painful, often require hospitalization, and contribute to disease complications and progression. Despite this recognition, there are currently no interventions to prevent AP episodes. In this retrospective cohort study, we assessed the impact of pancreatic enzyme therapy (PERT) use on clinical outcomes among children with pancreatic-sufficient ARP or CP.

METHODS

Children with pancreatic-sufficient ARP or CP in the INSPPIRE-2 cohort were included. Clinical outcomes were compared for those receiving vs not receiving PERT, as well as frequency of AP before and after PERT. Logistic regression was used to study the association between development of AP episodes after starting PERT and response predictors.

RESULTS

Among 356 pancreatic-sufficient participants, 270 (76%) had ARP, and 60 (17%) received PERT. Among those on PERT, 42% did not have a subsequent AP episode, during a mean 2.1 years of follow-up. Children with a SPINK1 mutation ( P = 0.005) and those with ARP (compared with CP, P = 0.008) were less likely to have an AP episode after starting PERT. After initiation of PERT, the mean AP annual incidence rate decreased from 3.14 down to 0.71 ( P < 0.001).

DISCUSSION: In a retrospective analysis, use of PERT was associated with a reduction in the incidence rate of AP among children with pancreatic-sufficient ARP or CP. These results support the need for a clinical trial to evaluate the efficacy of PERT to improve clinical outcomes among children with ARP or CP.

Для цитирования: Freeman Alvin Jay, Ng Kenneth, Wang Fuchenchu, Abu-El-Haija Maisam A, Chugh Ankur, Cress Gretchen A, Fishman Douglas S, Gariepy Cheryl E, Giefer Matthew J, Goday Praveen, Gonska Tanja Y, Grover Amit S, Lindblad Douglas, Liu Quin Y, Maqbool Asim, Mark Jacob A, McFerron Brian A, Mehta Megha S, Morinville Veronique D, Noel Robert A, Ooi Chee Y, Perito Emily R, Schwarzenberg Sarah Jane, Sellers Zachary M, Wilschanski Michael, Zheng Yuhua, Yuan Ying, Andersen Dana K, Lowe Mark E, Uc Aliye, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). Pancreatic Enzyme Use Reduces Pancreatitis Frequency in Children With Acute Recurrent or Chronic Pancreatitis: A Report From INSPPIRE.. The American journal of gastroenterology. 2024. DOI: 10.14309/ajg.0000000000002772.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.